JPRN-UMIN000023676
Recruiting
未知
Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneration - Intravitreal anti-VEGF therapy for AMD
Conditionsage-related macular degeneration
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- age-related macular degeneration
- Sponsor
- Kawasaki Medical School
- Enrollment
- 500
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Intravitreal anti-VEGF Therapies for Macular Edema Folowing Retinal Vein OcclusioRetinal vein occlusionJPRN-UMIN000023005Kawasaki Medical School33
Completed
Phase 4
Early anti-VEGF Therapy Intervention for Retinal Vein OcclusioRetinal vein occlusionJPRN-UMIN000026173Kyoto Prefectural Univerisity of Medicine50
Completed
Not Applicable
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disordersIRCT138902113846N1Shiraz University of Medical Sciences30
Completed
Not Applicable
Intravitreal Injections by Nurses and Physicians ComparedEye DiseasesNCT02359149St. Olavs Hospital328
Completed
Not Applicable
Intravitreal injection of anti vascular endothelial growth factor agent, Lucentis (ranibizumab), for the treatment of retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000013975agoya University hospital ophtalmoligy30